NOVI, MI, UNITED STATES, February 16, 2024 /EINPresswire.com/ -- Atropine Sulfate Injection stands as a cornerstone in emergency medicine, renowned for its pivotal ...

and its flatter structure in myopic eyes contributes to the condition. The lens behind the iris also contributes to refracting the light, but its role remains unchanged in myopic eyes. Atropine, a ...

SYD-101 (atropine sulfate ophthalmic solution 0.01% and 0.03%, Sydnexis) is an investigational formulation that is being evaluated in the phase 3 STAAR study in the United States and Europe ...

--(BUSINESS WIRE)--Medefil, Inc., a domestic manufacturer of injectable products, has announced availability of its FDA-approved ANDA products, Atropine Sulfate Injection, USP, 1 mg per 10 mL (0.1 ...